Wealth Enhancement Advisory Services
ALT icon

Wealth Enhancement Advisory Services’s Altimmune ALT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3K Buy
+25,989
New +$77.6K ﹤0.01% 3845
2025
Q3 		– Sell
-24,828
Closed -$118K – 3587
2025
Q2 		$118K Buy
24,828
+10,264
+70% +$55.5K ﹤0.01% 3111
2025
Q1 		$72.8K Sell
14,564
-1,024
-7% -$6.49K ﹤0.01% 2814
2024
Q4 		$112K Buy
15,588
+5,956
+62% +$45.5K ﹤0.01% 2793
2024
Q3 		$59.1K Sell
9,632
-8
-0.1% -$54 ﹤0.01% 2607
2024
Q2 		$64.1K Buy
+9,640
New +$71.1K ﹤0.01% 2441

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's ALT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Altimmune (ALT) in Q2 2026: 25,989 shares worth $79.3K. The stake represents ﹤0.01% of the portfolio and ranks #3845 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in ALT as recently as Q2 2025.

Wealth Enhancement Advisory Services first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $118K in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 25,989 shares of Altimmune worth $79.3K as of Q2 2026.
  • Altimmune was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Altimmune made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3845 holding.
  • Wealth Enhancement Advisory Services first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
  • Wealth Enhancement Advisory Services's Altimmune position peaked at $118K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.